Cafepharma Today

January 31 2025 - AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Novartis posts better-than-expected fourth-quarter sales
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Executive: Health reform, focus on chronic diseases leave Johnson & Johnson poised for growth
Yahoo/AP
Tuesday, May 12, 2009 - 4:39pm
tags:
JNJ
PhRMA Statement on Healthcare Reform Coalition
PR Newswire
Tuesday, May 12, 2009 - 4:37pm
tags:
PhRMA, healthcare reform
Lilly Set to Unveil More Than 50 Studies at ASCO 2009
Yahoo
Tuesday, May 12, 2009 - 9:44am
tags:
ASCO, Eli Lilly, cancer
Cell Therapeutics: Don't Fall for This Trap
TheStreet.com
Tuesday, May 12, 2009 - 9:43am
tags:
Cell Therapeutics
Arena Pharma 1Q loss narrows on lower costs
Yahoo/AP
Tuesday, May 12, 2009 - 9:42am
tags:
Arena Pharmaceuticals, earnings
Bristol-Myers to confirm earnings forecast
Marketwatch
Tuesday, May 12, 2009 - 9:40am
tags:
earnings, Bristol-Myers Squibb
GlaxoSmithKline buys 16 percent stake in South Africa's Aspen by transferring assets
Yahoo/AP
Tuesday, May 12, 2009 - 9:40am
tags:
GSK, Aspen
Exelixis and Boehringer Ingelheim form research collaboration
Pharmaceutical Business Review
Tuesday, May 12, 2009 - 7:35am
tags:
Boehringer Ingelheim, partnerships, Exelixis
Daiichi's Ranbaxy Buy a Harsh Lesson
WSJ Online
Tuesday, May 12, 2009 - 7:34am
tags:
Daiichi Sankyo, Ranbaxy, buyouts
Illumina Settles In A Flat Base After Faltering
Yahoo/Investors Business Daily
Tuesday, May 12, 2009 - 7:32am
tags:
Illumina
FDA Calendar Updates: Royal Returns for King Pharma
Seeking Alpha
Tuesday, May 12, 2009 - 7:31am
tags:
FDA, King
Cypress Bioscience: Investing in Pain
Seeking Alpha
Tuesday, May 12, 2009 - 7:11am
tags:
Cypress Bioscience, fibromyalgia
Icahn Suggests Biogen Split Cancer, Neurology Lines
Bloomberg
Tuesday, May 12, 2009 - 7:10am
tags:
Carl Icahn, Biogen Idec, neurology, oncology
Merck Wins Extension to Appeal Vioxx Certification in Ontario
Bloomberg
Tuesday, May 12, 2009 - 7:09am
tags:
Merck, Canada, Vioxx
Swine flu vaccine manufacturers gear up
FT.com
Monday, May 11, 2009 - 7:22pm
tags:
swine flu, vaccines, MedImmune, Solvay, Baxter International, GSK, Novartis, CSL
Valeant Over 200-day Moving Average
Yahoo/Zacks.com
Monday, May 11, 2009 - 7:19pm
tags:
Valeant Pharmaceuticals
Vanda, Up 800%, Still Has Room to Rise
TheStreet.com
Monday, May 11, 2009 - 7:18pm
tags:
Vanda, Fanapt
Danish drug maker Novo Nordisk agrees to pay $9M in oil-for-food kickback scheme with Saddam
Yahoo/AP
Monday, May 11, 2009 - 4:08pm
tags:
Novo Nordisk
Warner Chilcott 1Q profit jumps 29 percent
Yahoo/AP
Monday, May 11, 2009 - 4:07pm
tags:
Warner Chilcott, earnings
Merck and Elsevier Cross the Line in Joint Medical 'Journal'
Seeking Alpha
Monday, May 11, 2009 - 4:07pm
tags:
Merck, Elsevier

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Unlocking AI’s Promise in Patient Support Programs
Drug Channels
Right There At the Electrode
In the Pipeline
Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline

Latest Jobs

Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Midland, TX
Midland, Texas, US
Lundbeck
Psychiatry Account Manager - Newport News, VA
Newport News, Virginia, US
Lundbeck
Psychiatry Account Manager - Saint Louis South, MO
Saint Louis, Missouri, US
Lundbeck
Psychiatry Account Manager - Macon, GA
Macon, Georgia, US
Lundbeck
Psychiatry Account Manager - Plano, TX
Plano, Texas, US
Lundbeck
Psychiatry Account Manager - College Station, TX
College Station, Texas, US
Lundbeck
Pharmaceutical Sales Representative- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Manager, Associates Membership Sales
Alexandria, Virginia, United States
Health Industry Distributors Association
Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Jacksonville, Florida
Eli Lilly and Company
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information